Page 2 - Les meilleurs doctors traitant la maladie suivante : Lymphangiome - TOP -44 des médecins

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Plus de 30 ans de spécialisation en virothérapie – Le Dr Jaunalksne applique des approches immunologiques novatrices à la clinique Pallas.

• Responsable du centre d'immunologie clinique de l'hôpital universitaire Pauls Stradins
• Diplômée de l'Institut médical de Riga avec un internat en médecine interne
• Spécialisée dans les traitements innovants pour les conditions liées à l'immunité

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Topcu apporte une expertise spécialisée en oncologie aux cas de lymphangiome, avec une formation dans les plus grands centres de cancérologie internationaux.

• Résidence en oncologie médicale à l'Université Technique de Karadeniz
• Formé au MD Anderson Cancer Center et au Moffitt Cancer Center
• Membre des sociétés professionnelles ESMO et ASCO
• Exerce à l'hôpital universitaire Biruni

Spécialisé en oncologie radiothérapique à l'Université de Marmara – formé spécifiquement pour les pathologies lymphatiques complexes.

• Diplômé de la faculté de médecine de l'Université de Marmara
• Avoir terminé sa spécialisation en oncologie radiothérapique
• Travailler à l'hôpital Emsey

Plus de 30 000 TEP et 1 000 patients atteints de cancer de la thyroïde traités – Le Dr Borde est spécialisé en médecine nucléaire au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Maîtrise des thérapies à l'iode radioactif et au Lu-177 RN
• Expert en examens TEP-TDM et services de cardiologie nucléaire
• Recherches publiées dans plusieurs revues médicales

Le Dr Sridhar P.S. est spécialisé en radiothérapie avec une formation approfondie en oncologie, se concentrant sur des approches de traitement précises et efficaces.

• Plus de 20 ans d'expérience en radiothérapie
• Diplômé du National Board en radiothérapie
• Membre de la Society for Neuro-Oncology
• Associé à l'Indian Association of Hyperthermia Oncology

Le professeur Kayihan Engin possède plus de 30 ans d'expertise en radio-oncologie, avec une formation spécialisée à l'université Thomas Jefferson.

• Ancien président du département de radio-oncologie à l'université d'Uludağ
• Stage postdoctoral en thermoradiothérapie aux États-Unis
• Directeur des sciences oncologiques à l'hôpital Medicana Bursa
• Bourse de recherche au National Cancer Institute, États-Unis

Avec plus de 20 ans d'expérience, le Dr Ugur Ekici, professeur associé, est spécialisé en chirurgie laparoscopique avancée et en chirurgie oncologique à l'hôpital Medicana Bahcelievler.

• Se former à la clinique de chirurgie générale de l'hôpital Şişli Etfal
• Publier des articles dans des revues internationales à comité de lecture
• Se spécialiser dans les chirurgies de l'obésité, métaboliques, de la thyroïde et des parathyroïdes

Spécialiste en hématologie et oncologie pédiatriques avec plus de deux décennies d'expérience, dirigeant actuellement l'unité d'hématologie et d'oncologie pédiatriques de l'hôpital HM Montepríncipe.

• Expert dans le traitement des tumeurs osseuses et cérébrales
• Spécialisé dans la leucémie et les maladies hématologiques
• Auteur de nombreuses publications scientifiques nationales et internationales
• Formé à l'Université du Maryland en hématologie et oncologie pédiatriques